Neil Haimm

Neil K. Haimm is a partner in the Corporate and Securities Practice Group and one of the managing partners of the firm. He has been a corporate lawyer for more than 30 years. Neil’s practice focuses primarily on acquisitions and divestitures, joint ventures and other strategic transactions and venture capital and private equity investments.

Acquisitions and Divestitures. Neil represents companies and private equity funds in merger and acquisition activities.

Joint Ventures and Strategic Transactions. Neil represents technology and life sciences companies in the formation of joint ventures and in other strategic transactions. In recent years, he has represented Endo Pharmaceuticals in licensing of intellectual property and product development agreements with various biotech and pharmaceutical companies and in other strategic relationships.

Background. Neil received his undergraduate degree from the University of Pennsylvania and law degree and masters in taxation from New York University School of Law. Neil is admitted to practice law in New York, New Jersey and Pennsylvania. He is a Vice President of the Golden Slipper Senior Center, a center serving needs and sponsoring activities for seniors. He is also Vice President of Golden Slipper Charities, a Delaware Valley-based philanthropy. In addition, Neil serves as a member of the board of directors of the Association for Corporate Growth in the Philadelphia Region.

 



From the Blog

Overlapping Post-Marketing Challenges for Biopharmaceuticals: Pharamacovigilance, Products Liability, and Biosmiliars

Krista Cosner published, “Overlapping Post-Marketing Challenges for Biopharmaceuticals: Pharmacovigilance, Products Liability, and Biosimilars,” in the following publications: Bloomberg Services (May 16), BioTech Watch (May...

Privately Held Medical Device and Drug Companies Face Unique Sunshine Act Challenges

As widely reported, the Centers for Medicare and Medicaid Services (“CMS”) recently issued regulations implementing the Sunshine Act provisions of the Affordable Care Act. ...

What Goes Up…Must Come Down: Viagra patent invalidated by Canadian Supreme Court

Pfizer and Teva have been fighting a legal battle over Pfizer’s patent for Viagra in Canada.  The first shot was fired when Novopharm Limited,...